- Otis Brawley: Experts recommend doctor-patient talk on risks, benefits before screening
- He says PSA screening has been contentious from beginning, and new approach will help
Otis Brawley is chief medical officer of the American Cancer Society. The opinions expressed in this commentary are his.
(CNN)Prostate screening has been a contentious issue ever since the prostate specific antigen, or PSA, test became available some 30 years ago. Prostate cancer is the third most common cause of cancer death among American men, behind lung cancer and colorectal cancer; it is clearly a disease where effective screening and treatment is needed.